RDYDr. Reddy's Laboratories Limited
$12.83-12% 1Y
$12.83
$11.4052 weeks$15.25
Price
-12%1YEnd-of-day closes, not the intraday tick.
More going right than wrong
Quality mixed, nothing alarming, growing in the filings, the market undecided.
What they do
Established in 1984, we are an integrated global pharmaceutical company committed to accelerating access to affordable and innovative medicines. Our reportable operating segments are as follows:
In the company’s own words · 20-F filed May 29, 2026 · SEC EDGAR
P/En/a
Market value$12.70B
1 year-12%
5 years-0.75%
Charts
As reported to the SEC, without any scoring.
For the full year FY2025, revenue was INR 325.5B (+17% year on year) and net income INR 56.5B.
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.
Drug Manufacturers, Specialty & Generic
Ranks #3 of 41 by RyuScore